The BNP And NTproBNP Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The BNP And NTproBNP Market:
https://www.thebusinessresearchcompany.com/report/bnp-and-ntprobnp-global-market-report
According to The Business Research Company’s BNP And NTproBNP Global Market Report 2024, The bnp and ntprobnp market size has grown rapidly in recent years. It will grow from $1.77 billion in 2023 to $2 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to aging population, clinical utility in heart failure diagnosis, advancements in cardiovascular medicine, focus on preventive healthcare
The bnp and ntprobnp market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing cardiovascular disease burden, integration into point-of-care testing, expanding applications in other medical conditions, personalized medicine approaches, telemedicine and remote monitoring. Major trends in the forecast period include technological advancements in assay methods, personalized medicine approaches, biomarker in predicting prognosis, emergence of novel biomarkers, global standardization efforts.
The rising prevalence of cardiovascular diseases is expected to propel the growth of the BNP and NTproBNP market going forward. Cardiovascular diseases are disorders that affect the heart and blood vessels, such as peripheral arterial disease, cerebrovascular disease, coronary heart disease, and others. BNP and NTproBNP tests deal with heart health and safety monitoring, determining factors contributing to the cardiovascular disease before disease occurrence, thereby helping in taking preventative measures and reducing the chance of mortality. For instance, in March 2022, according to the Office for National Statistics, a UK-based statistics authority that reports directly to the UK Parliament, the number of deaths due to a heart attack as an underlying cause increased from 19,440 in 2020 to 20,061 in 2021. The rising prevalence of cardiovascular diseases is driving the BNP and NTproBNP markets.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10673&type=smp
The bnp and ntprobnp market covered in this report is segmented –
1) By Type: BNP (Brain Natriuretic Peptide), NT-proBNP (N-terminal Pro–B-Type Natriuretic Peptide)
2) By Location Of Testing: Point Of Care Testing, Laboratory Testing
3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Other Applications
Product innovation is a key trend gaining popularity in the BNP and NTproBNP markets. Major companies in the BNP and NTproBNP markets are introducing innovative products to sustain their position in the market. For instance, in May 2023, Randox Laboratories, a UK-based health, toxicology, and diagnostics company, launched a BNP1-32 diagnostic test for the diagnosis of heart failure. The automated test measures levels of BNP (B-type natriuretic peptide), a protein produced by the heart and blood vessels, with high sensitivity and specificity. This control is used with the Acusera range of third-party controls and Acusera 24.7 software that supports monitoring and representing QC data. The BNP control provides an independent and unbiased assessment of analytical performance, ensuring reliable and accurate testing for BNP.
The bnp and ntprobnp market report table of contents includes:
1. Executive Summary
2. BNP And NTproBNP Market Characteristics
3. BNP And NTproBNP Market Trends And Strategies
4. BNP And NTproBNP Market – Macro Economic Scenario
5. Global BNP And NTproBNP Market Size and Growth
.
.
.
26. South America BNP And NTproBNP Market
27. Brazil BNP And NTproBNP Market
28. Middle East BNP And NTproBNP Market
29. Africa BNP And NTproBNP Market
30. BNP And NTproBNP Market Competitive Landscape And Company Profiles
Top Major Players:
- Abbott Laboratories
- Gentian Diagnostics ASA
- Siemens AG
- PerkinElmer Inc
- Biomerieux SA
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
